The rapid growth of the Russian pharmaceutical market — which is expected to increase by 20 percent in 2008 to $17 billion and by another 13 percent in 2009 to $19.2 billion — makes the U.S. and Europe seem sluggish in comparison.
Pharmaceutical companies don’t want to be left behind and miss out on the opportunity to maximize their sales potential in this ballooning market. But doing business in Russia can be very risky.
Not only is Russia’s regulatory policy on drugs excessive, it’s also arbitrarily implemented with little regard to international regulations.
Imagine trying to keep up with:
Now you can get insider information on how to overcome these hurdles and get a handle on the regulatory environment in Russia. Experts Svetlana Rudevich and Julianna Tabastajewa share their real-world experiences so you can get your drugs through the Russian regulatory maze and onto the market.
Order now your entire team to listen in and discover:
You won’t want to miss out on this great opportunity to get your drugs into the hottest market in the world!
This audio CD/Transcript is a must for positions in drug and biotech companies, including:
Svetlana Rudevich of Hogan and Hartson, LLP, has extensive experience in various Russian corporate transactions, including cross-border mergers and acquisitions; setting up equity and debt financing; restructuring and liquidation of business operations; regulatory issues, including antitrust, currency control, customs, consumer protection and products compliance legislation; and a wide variety of labor law issues. Svetlana advises pharmaceutical companies on various legal and commercial issues related to the access of consumer goods and pharmaceuticals to the Russian market, including product compliance, certification and customs clearance.
Julianna Tabastajewa of Hogan and Hartson, LLP, focuses her practice on intellectual property protection and litigation, pharmaceutical law, competition law, media law and franchising. Julianna advises pharmaceutical and medical device companies on issues such as performing clinical trials and importing and distributing pharmaceutical products in Russia. She also has extensive experience in domestic litigations and arbitration in Russia. Julianna has contributed significantly to new domain regulations in the Russian Federation and has written extensively on the subject.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing